Apheresis for CIDP (Chronic inflammatory demyelinating polyneuropathy)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder of the peripheral nervous system associated with autoimmune antibodies of the IgG4 type. Immunoadsorption/apheresis in CIDP proves effective in removing antibodies associated with CIDP.
Recent studies demonstrate its clinical efficacy, establishing Immunoadsorption/apheresis as a valuable therapeutic alternative for both short-term and long-term CIDP treatment.
“Our results suggest that IA might constitute a promising and well-tolerated therapeutic alternative in CIDP for short-term and long-term treatment. We showed that long-term treatment with IA in regular intervals can stabilize the course of disease at least in a subgroup of patients.”
Dorst et al. J Nerol 2018